← Leaderboards
Amy E Geddis
University Of Washington
$1,594,963
Attributed
$2,575,826
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $370.8K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,575,826 · 4
By mechanism
R01$1,726,114 · 1
K08$612,900 · 1
R56$235,613 · 1
M01$1,199 · 1
Top collaborators
- Kenneth Kaushansky7 shared
Most similar at University Of Washington
Same institution · by research overlap
- Kenneth Kaushansky$9,324,127
- C. Anthony Blau$17,614,130
- Andrew A Aprikyan$1,101,576
- Janis L Abkowitz$28,579,442
- Daniel E Sabath$3,938,304
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationMimeticsCell SurvivalLinkErythropoietinMegakaryocytopoiesesAccountingEndosomesErythropoietin ReceptorLaboratory MouseErythropoiesisCell LineLysosomesCellsEtiologyBenignBlood PlateletsEndocytosisBinding (Molecular Function)CytokineFinancial CompensationGlycosylationCell Growth RegulationLoss Of Function
Grant awards (14)
Molecular and Cellular Biology of Thrombopoietin$318,862
R01 · FY2013 · DK
Molecular and Cellular Biology of Thrombopoietin$334,680
R01 · FY2012 · DK
Molecular and Cellular Biology of Thrombopoietin$334,680
R01 · FY2011 · DK
Molecular and Cellular Biology of Thrombopoietin$271,506
R01 · FY2010 · DK
Molecular and Cellular Biology of Thrombopoietin$95,586
R01 · FY2010 · DK
Molecular and Cellular Biology of Thrombopoietin$370,800
R01 · FY2009 · DK
Molecular and Cellular Biology of Thrombopoietin$235,613
R56 · FY2008 · DK
THE ROLE OF PL3K IN THROMBOPOIETIN SIGNALING$121,770
K08 · FY2005 · HL
ANTI-IDIOTYPE MONOCLONAL ANTIBODY AS A TUMOR VACCINE FOR NEUROBLASTOMA$610
M01 · FY2005 · RR
THE ROLE OF PL3K IN THROMBOPOIETIN SIGNALING$121,770
K08 · FY2004 · HL
Anti-Idiotype MAB as a Tumor Vaccine for Neuroblastoma$589
M01 · FY2004 · RR
THE ROLE OF PL3K IN THROMBOPOIETIN SIGNALING$121,770
K08 · FY2003 · HL
THE ROLE OF PL3K IN THROMBOPOIETIN SIGNALING$121,770
K08 · FY2002 · HL
THE ROLE OF PL3K IN THROMBOPOIETIN SIGNALING$125,820
K08 · FY2001 · HL